Background Trimethylamine‐N‐oxide (TMAO), a diet‐derived, gut microbial–host
cometabolite, has been associated with adverse cardiovascular outcomes in patient …

Introduction Gut microbiota-dependent trimethylamine-N-oxide (TMAO) correlates with
arterial thrombotic events including myocardial infarction and stroke, and mortality. However …

Trimethylamine N-oxide (TMAO) is a molecule generated from choline, betaine, and
carnitine via gut microbial metabolism. The plasma level of TMAO is determined by several …

Abstract Background Trimethylamine-N-oxide (TMAO) is a metabolite of phosphatidylcholine
generated by gut microbiota and liver enzymes, and has recently been recognized as …

The extensive collection of bacteria cohabiting within the host collaborates with human
functions and metabolisms in both health and disease. The fine equilibrium of commensals …

Morbidity and mortality of cardiovascular diseases (CVDs) are exceedingly high worldwide.
Researchers have found that the occurrence and development of CVDs are closely related …

Abstract Trimethlyamine-N-oxide (TMAO) was recently identified as a promoter of
atherosclerosis. Patients with CKD exhibit accelerated development of atherosclerosis; …

Diet and microbiota each have a direct impact on many chronic, inflammatory, and metabolic
diseases. As the field develops, a new perspective is emerging. The effects of diet may …

Background Trimethylamine‐N‐oxide (TMAO), a metabolite derived from gut microbes and
dietary phosphatidylcholine, is linked to both coronary artery disease pathogenesis and …

ABSTRACT Background Trimethylamine N-oxide (TMAO) is a diet-and microbiome-derived
metabolite and a proposed biomarker of adverse cardiometabolic outcomes. TMAO studies …